Tag archive for ‘Cryoport support of cell therapy products’
Cryoport: We Are Just in the First Inning (CYRX, Buy, $50.27)
Key Investment Points I continue to be very bullish on the long term outlook for Cryoport. Listed below are some of the key points that investors should focus on. In past reports, I have emphasized that Cryoport sales stemming from support of commercial products was key to my projections for rapid sales growth. Almost all […]